Today's Pre-Open Stock Movers

RR Donnelley (NYSE: RRD) 29.6% HIGHER; reported Q1 EPS of $0.33, $0.37 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $1.41 billion versus the consensus estimate of $1.38 billion.

Blue Apron (NYSE: APRN) 25.2% LOWER; reported Q1 EPS of ($1.51), $0.01 worse than the analyst estimate of ($1.50). Revenue for the quarter came in at $101.9 million versus the consensus estimate of $107.5 million. Blue Apron sees Q2 2020 revenue of $130 million, versus the consensus of $118.3 million.

Chimerix (NASDAQ: CMRX) 22.5% HIGHER; announced that the Company has received clearance from the U.S. Food and Drug Administration (FDA) for a rolling submission of its New Drug Application (NDA) for the approval of brincidofovir (BCV) as a medical countermeasure for smallpox. The Company intends to begin the rolling NDA submission for BCV in May 2020 with completion targeted for mid-2020. Chimerix is developing BCV as a potential medical countermeasure for smallpox under an ongoing collaboration and funding provided by the Biomedical Advanced Research and Development Authority (BARDA), part of the office of the Assistant Secretary for Preparedness and Response within the U.S. Department of Health and Human Services, under ongoing USG Contract No HHSO10201100013C.

Brinker International (NYSE: EAT) 15.5% HIGHER; reported Q3 EPS of $1.28, $0.58 better than the analyst estimate of $0.70. Revenue for the quarter came in at $860 million versus the consensus estimate of $865.88 million.

Accuray (NASDAQ: ARAY) 14.9% HIGHER; reported Q3 EPS of $0.03, $0.07 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $99.5 million versus the consensus estimate of $97.26 million.

Marker Therapeutics, Inc. (NASDAQ: MRKR) 14.7% HIGHER; granted FDA Orphan Drug Status

Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL) 7.9% HIGHER; reported Q1 EPS of $9.87, $0.46 worse than the analyst estimate of $10.33. Revenue for the quarter came in at $41.16 billion versus the consensus estimate of $40.38 billion.

INOVIO (NASDAQ: INO) 7.6% HIGHER; INOVIO and GeneOne Life Science (KSE:011000) today announced interim data through week 16 from a Phase 1/2a trial of DNA vaccine INO-4700 (also called GLS-5300) for MERS coronavirus (MERS-CoV). Vaccine recipients demonstrated strong antibody and T cell immune responses after 2 or 3 doses with 0.6 mg of INO-4700, a DNA vaccine that targets the MERS-CoV Spike (S) glycoprotein, delivered with intradermal CELLECTRA® device. The vaccination regimen was well-tolerated with no vaccine-associated severe adverse events (SAEs). The researchers at the Wistar Institute, Seoul National University Hospital, and the International Vaccine Institute (IVI) collaborated on this study with funding from IVI. These results were selected for an oral presentation at the American Society of Gene & Cell Therapy (ASGCT) Conference to be held virtually from May 12-15, 2020.

Weight Watchers International, Inc. (NASDAQ: WW) 7.5% HIGHER; reported Q1 EPS of ($0.09), $0.14 better than the analyst estimate of ($0.23). Revenue for the quarter came in at $400 million versus the consensus estimate of $399.96 million.

Tupperware Brands (NYSE: TUP) 7% LOWER; reported Q1 EPS of $0.09, $0.47 worse than the analyst estimate of $0.56. Revenue for the quarter came in at $375.9 million versus the consensus estimate of $396.58 million. Full year 2020 guidance withdrawn due to material uncertainty of duration and extent of COVID-19 pandemic impact.

iRobot Corp. (NASDAQ: IRBT) 6.2% LOWER; reported Q1 EPS of ($0.32), $0.15 better than the analyst estimate of ($0.47). Revenue for the quarter came in at $192.5 million versus the consensus estimate of $178.86 million. On March 23, 2020, iRobot withdrew its financial expectations for 2020.

Werner Enterprises (NASDAQ: WERN) 5.6% HIGHER; reported Q1 EPS of $0.40, $0.05 better than the analyst estimate of $0.35. Revenue for the quarter came in at $592.7 million versus the consensus estimate of $576.87 million.

DexCom (NASDAQ: DXCM) 5.2% HIGHER; reported Q1 EPS of $0.44, $0.30 better than the analyst estimate of $0.14. Revenue for the quarter came in at $405.1 million versus the consensus estimate of $357.64 million.

Boeing (NYSE: BA) 5% HIGHER; reported Q1 EPS of ($1.70), $0.09 worse than the analyst estimate of ($1.61). Revenue for the quarter came in at $16.91 billion versus the consensus estimate of $17.31 billion. Boeing is taking several actions that include reducing commercial airplane production rates. In addition, the company believes it will be able to obtain sufficient liquidity to fund its operations.

Hasbro (NASDAQ: HAS) 5% LOWER; reported Q1 EPS of $0.57, $0.01 worse than the analyst estimate of $0.58. Revenue for the quarter came in at $1.11 billion versus the consensus estimate of $1.14 billion. Withdrawing 2020 Guidance: Due to the uncertainty related to COVID-19 including its impact on the Company's supply chain, global retailer operations, timing and production of entertainment and the global macroeconomic environment, the Company is withdrawing its 2020 Outlook issued at its Toy Fair presentation on February 21, 2020.

Zoom (NASDAQ: ZM) 4.5% LOWER; Google (NASDAQ: GOOGL) said any user will soon be able to host free video conferences on Meet.

Ford Motor (NYSE: F) 4.3% LOWER; reported Q1 EPS of ($0.23), $0.11 worse than the analyst estimate of ($0.12). Revenue for the quarter came in at $34.3 billion versus the consensus estimate of $32.54 billion. In March, the company withdrew guidance for 2020 financial performance it had given in early February. That outlook excluded possible implications of the coronavirus, which at the time had not yet reached pandemic stage.

FireEye (NASDAQ: FEYE) 4.3% LOWER; reported Q1 EPS of ($0.02), $0.02 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $225 million versus the consensus estimate of $221.28 million. FireEye sees Q2 2020 EPS of ($0.03)-($0.01), versus the consensus of $0.02. FireEye sees Q2 2020 revenue of $213-217 million, versus the consensus of $222.95 million. FireEye sees FY2020 EPS of $0.03-$0.07, versus the consensus of $0.17. FireEye sees FY2020 revenue of $880-900 million, versus the consensus of $920.2 million.

Akamai Technologies (NASDAQ: AKAM) 4.2% LOWER; reported Q1 EPS of $1.20, $0.04 better than the analyst estimate of $1.16. Revenue for the quarter came in at $764 million versus the consensus estimate of $749.76 million.

Advanced Micro Devices, Inc. (NASDAQ: AMD) 3.2% LOWER; reported Q1 EPS of $0.18, in-line with the analyst estimate of $0.18. Revenue for the quarter came in at $1.79 billion versus the consensus estimate of $1.78 billion. Advanced Micro Devices, Inc. sees Q2 2020 revenue of $1.85 billion plus or minus $100 million, versus the consensus of $1.92 billion.

General Electric (NYSE: GE) 2.9% LOWER; reported Q1 EPS of $0.05, $0.03 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $20.52 billion versus the consensus estimate of $20.23 billion. Given the evolving nature of the COVID-19 pandemic, at this time, GE cannot forecast with reasonable accuracy the full duration, magnitude, and pace of recovery across our end markets, operations, and supply chains. As a result, on April 9, 2020, GE withdrew its guidance for 2020.

aycom Software (NYSE: PAYC) 2.8% LOWER; reported Q1 EPS of $1.33, $0.06 better than the analyst estimate of $1.27. Revenue for the quarter came in at $242.4 million versus the consensus estimate of $238.83 million. Paycom is withdrawing its previously issued full-year 2020 guidance in light of macroeconomic uncertainties, particularly unemployment, arising from the current COVID-19 crisis.

General Dynamics (NYSE: GD) 1.9% LOWER; reported Q1 EPS of $2.43, $0.14 worse than the analyst estimate of $2.57. Revenue for the quarter came in at $8.75 billion versus the consensus estimate of $9.23 billion.